Quoin Pharmaceuticals, Ltd. (QNRX) Financials
QNRX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 15.7 million | 6.9 million |
| Dec. 31, 2025 | 20.4 million | 7.3 million |
| Sept. 30, 2025 | 6.4 million | 7.6 million |
| June 30, 2025 | 8.9 million | 6.4 million |
QNRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -4.9 million | 444525 |
| Dec. 31, 2025 | -5.1 million | 1.1 billion |
| Sept. 30, 2025 | -2.2 million | 182000 |
| June 30, 2025 | -3.7 million | 321000 |
QNRX Net Income
No data available :(
QNRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 3.1 million | - | - |
| Dec. 31, 2025 | 3.8 billion | - | - |
| Sept. 30, 2025 | 5.4 million | - | - |
| June 30, 2025 | 7.8 million | - | - |
QNRX Shares Outstanding
QNRX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 3.4 million | 1.7 million | -4602 |
| Dec. 31, 2025 | 4 | 3.1 million | 1.4 million | - |
| Sept. 30, 2025 | - | 2.3 million | 1.7 million | - |
| June 30, 2025 | 3 | 2.1 million | 1.7 million | - |
QNRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 24932 |
| Dec. 31, 2025 | - | 25156 |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 25520 |
QNRX
Price: $4.65
52 week price:
Earnings Per Share: -10.07 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 102500
Market Capitalization: 2.6 million